REVEALED: Nuvalent | Vintage Vibes

Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion

GSK agreed to acquire Nuvalent for $10.6 billion, or $124 per share, a roughly 40% premium, to add two late-stage lung cancer assets and offset an impending patent cliff.

MarketBeat · Jun 11

Nuvalent Stock Hits All-Time High Following GSK's Buyout Offer

Nuvalent shares soar as GSK announces a $10.6 billion buyout deal. But is it too late already to invest in NUVL stock?

Barchart · Jun 9

Why is the US stock market crashing today? S&P 500 erases all gains and wipes out $1.3 trillion in 2 hours as Nasdaq and Dow turn sharply lower - Tech stocks and chip sector collapse

The US stock market crash today caught many investors off guard. Early gains quickly vanished as the S&P 500 erased more than $1.3 trillion in market value within just two hours. What began as a relief rally suddenly turned into a broad sell-off that dragged down the Nasdaq, Nvidia, Apple,…

The Economic Times · Jun 9

GSK to buy US lung cancer drug specialist Nuvalent for £8bn

The acquisition is thought to be GSK’s biggest deal in more than a decade.

Evening Standard · Jun 9

Nuvalent Reports 31% Response Rate In Patients With Advanced Form Of Lung Cancer

Nuvalent, Inc. (NASDAQ:NUVL) on Monday reported topline results from its ALKOVE-1 Phase 1/2 trial.

Benzinga · Nov 17, 2025

$21.8 Million Bet On Nuvalent? 4 Stocks Insiders Are Buying

Although US stocks closed higher on Monday, there were a few notable insider trades.

Benzinga · Nov 8, 2022

$7.8 Million Bet On Appian? 4 Stocks Insiders Are Buying

Although US stocks closed lower on Thursday, there were a few notable insider trades.

Benzinga · Nov 4, 2022